Olav Wendelboe Nielsen

Olav Wendelboe Nielsen

    Member of:

    • Internal medicine: Cardiology

    ORCID: 0000-0003-3532-9431

    Publication year:
    All
    1 - 7 out of 7Page size: 10
    1. 2019
    2. Published

      Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

      Anholm, C., Kumarathurai, P., Pedersen, L. R., Samkani, A., Walzem, R. L., Nielsen, Olav Wendelboe, Kristiansen, O. P., Fenger, M., Madsbad, Sten, Sajadieh, Ahmad & Haugaard, Steen Bendix, Sep 2019, In: Atherosclerosis. 288, p. 60-66 7 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Echocardiographic subtypes of heart failure in consecutive hospitalised patients with dyspnoea

      Nielsen, Olav Wendelboe, Valeur, N., Sajadieh, Ahmad, Fabricius-Bjerre, A., Carlsen, C. M. & Køber, Lars Valeur, 1 Jun 2019, In: Open Heart. 6, 1, 9 p., e000928.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

      Anholm, C., Kumarathurai, P., Samkani, A., Pedersen, L. R., Boston, R. C., Nielsen, Olav Wendelboe, Kristiansen, O. P., Fenger, M., Madsbad, Sten, Sajadieh, Ahmad & Haugaard, Steen Bendix, 2019, In: Diabetes, Obesity and Metabolism. 21, 8, p. 2012-2016 5 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    5. Published

      Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU

      Maggioni, A. P., López-Sendón, J., Nielsen, Olav Wendelboe, Hallén, J., Aalamian-Mattheis, M., Wang, Y. & Ertl, G., 2019, In: European Journal of Heart Failure. 21, 3, p. 322-333 12 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    6. Published

      Liraglutide improves the beta-cell function without increasing insulin secretion during a mixed meal in patients, who exhibit well-controlled type 2 diabetes and coronary artery disease

      Anholm, C., Kumarathurai, P., Jurs, A., Pedersen, L. R., Nielsen, Olav Wendelboe, Kristiansen, O. P., Fenger, M., Holst, Jens Juul, Madsbad, Sten, Sajadieh, Ahmad & Haugaard, Steen Bendix, 2019, In: Diabetology & Metabolic Syndrome. 11, 12 p., 42.

      Research output: Contribution to journal › Journal article › Research › peer-review

    7. Published

      Reproducibility of in-hospital worsening heart failure event adjudication in the RELAX-AHF-EU trial

      Hallén, J., Maggioni, A. P., Lopez-De-Sa, E., Turazza, F. M., Witte, K., Erdmann, E., Dahlström, U., Ertl, G., Nielsen, Olav Wendelboe, Sendon, J. L., Holbro, T., Chen, C., Gimpelewicz, C. & Cowie, M. R., 2019, In: European Journal of Heart Failure. 21, 12, p. 1661-1662 2 p.

      Research output: Contribution to journal › Letter › Research › peer-review

    8. Published

      Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial

      Düngen, H., Køber, Lars Valeur, Nodari, S., Schou, Morten, Otto, C., Becka, M., Kanefendt, F., Winkelmann, B. R., Gislason, Gunnar Hilmar, Richard, F., Nielsen, Olav Wendelboe, Gheorghiade, M. & Senni, M., 2019, In: Clinical Pharmacology in Drug Development. 8, 7, p. 942-951 10 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 43235532